Public Health

As physician shortages and student debt mount, a key medical institution doubles its scholarship program. Is this philanthropy, or a strategic pivot?

A New York non-profit's monthly alert reveals the street-level tactics of a massive illicit industry. But the real story is the multi-front war being waged by regulators and citizens against a fraud enterprise that costs taxpayers billions.

A major alliance of urban schools is reframing the lunch line as the front line of preventive healthcare, appointing a doctor to tackle childhood disease.

New UK safety rules for engineered stone reveal a deadly dust crisis. As regulators crack down, the industry faces a choice: control the risk or change the material.

Breast cancer survivor and marketing powerhouse Amber Guild takes the helm at Susan G. Komen, bringing a potent blend of personal insight and corporate strategy.

A new project-based scholarship from tech entrepreneur Jason Kulpa aims to turn personal tragedy into a launchpad for student-led solutions to the healthcare crisis.

As students face a choice between their health and education, one foundation offers direct aid. But does this agile approach mask a deeper systemic failure?

A bureaucratic blunder in Florida's Medicaid funding has ignited a legal battle, leaving millions of families fearing the loss of their children's doctors.

In rural North Carolina, a new model of emergency response is taking flight. Paramedics are now pilots, reaching patients minutes faster than ever before.

Former World Bank President Dr. Jim Yong Kim joins ImmunityBio. Is this a new model for biotech social impact or a high-stakes bet on global expansion?

Revvity's new SuperFlex system isn't just a new device; it's a strategic move to decentralize preeclampsia testing and capture an underserved market.

New models suggest vaping has saved thousands of lives, yet public debate remains mired in moral outrage. An analysis of the science, the policy, and the psychology behind the noise.

European approval for Bavarian Nordic's pediatric mpox vaccine is a critical health breakthrough and a masterclass in strategic market positioning.

Breakthroughs in blood-based diagnostics are revolutionizing Alzheimer's care, but a new analysis reveals that compassionate communication is just as vital.

As a major cyclospora outbreak sweeps the U.S., Roche's new research-only PCR tests provide a critical, behind-the-scenes tool for public health.

Cross-Border Impact Ventures secures a $58M first close for its second fund, targeting the vastly underserved but rapidly growing women's and children's health market.

A $125k donation offers a lifeline to 10,000 babies, but it also reveals a systemic issue affecting nearly half of U.S. families. Here's the real story.

A new partnership in LA sees a healthcare giant funding education. It’s not charity—it's a strategic bet on a new economic model for American healthcare.

In a county grappling with food insecurity, a new program delivers health through groceries. Here's how the Umoja-OCO partnership redefines care.

A little-known lung disease is on the rise, with diagnoses delayed for years. We explore why NTM is a growing public health challenge and how awareness is key.